层次聚类分析预测起始血液透析后1年死亡率
该前瞻性研究纳入101例新开始维持性血液透析的终末期肾病患者,利用46项临床变量进行层次聚类,分出3个簇。簇3患者透析前收缩压、血肌酐和尿L-FABP较低,1年死亡率最高(P<0.001),调整年龄和性别后风险比达10.2(95%CI 2.94-46.8)。
要点
- 层次聚类可识别透析起始时1年死亡风险更高的亚组。
- 簇3患者透析前收缩压、血肌酐和尿L-FABP水平较低。
- 簇3的1年死亡率显著最高,调整后HR为10.2。
核心结论
- 层次聚类发现起始血液透析患者中1年死亡率更高的亚组。
- 机器学习分类可能有助于终末期肾病患者更好的风险分层。
研究设计与样本
- 前瞻性研究,纳入2016年8月至2018年3月新开始维持性血液透析的终末期肾病患者101例。
- 透析前采集血液和尿液检测等基线变量,对连续数据进行凝聚层次聚类。
- 随访主要结局为1年死亡率,采用Kaplan-Meier生存曲线、log-rank检验和Cox比例风险模型分析。
主要发现
- 使用46项临床变量将患者分为3个簇:簇1(n=62)、簇2(n=15)、簇3(n=24)。
- 簇3患者透析前收缩压、血清肌酐和尿肝型脂肪酸结合蛋白水平较低。
- 簇3的1年死亡率最高(P<0.001),调整年龄和性别后差异仍显著,以簇1为参照的风险比为10.2(95%CI 2.94-46.8)。
临床怎么用
- 可考虑对起始血液透析患者采用聚类分析辅助风险分层。
- 对透析前收缩压、血肌酐和尿L-FABP较低的簇3特征患者加强随访。
局限性
- 为概念验证性研究,样本量101例。
- 单中心前瞻性设计,结果需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: For patients with end-stage renal disease (ESRD), due to the heterogeneity of the population, appropriate risk assessment approaches and strategies for further follow-up remain scarce. We aimed to conduct a pilot study for better risk stratification, applying machine learning-based classification to patients with ESRD who newly started maintenance hemodialysis. METHODS: We prospectively studied 101 patients with ESRD, who were new to maintenance hemodialysis therapy, between August 2016 and March 2018. Baseline values of variables such as blood and urine tests were obtained before the initiation of hemodialysis. Agglomerative hierarchical clustering was conducted with the collected continuous data. The resulting clusters were followed up for the primary outcome of 1-year mortality, as analyzed by the Kaplan-Meier survival curve with log-rank test and the Cox proportional hazard model. RESULTS: The participants were divided into 3 clusters (cluster 1, n = 62; cluster 2, n = 15; cluster 3, n = 24) by hierarchical clustering, using 46 clinical variables. Patients in cluster 3 showed lower systolic blood pressures, and lower serum creatinine and urinary liver-type fatty acid-binding protein levels, before the initiation of hemodialysis. Consequently, cluster 3 was associated with the highest 1-year mortality in the study cohort (P < 0.001), and the difference was significant after adjustment for age and sex (hazard ratio: 10.2; 95% confidence interval: 2.94-46.8, cluster 1 as reference). CONCLUSION: In this proof-of-concept study, hierarchical clustering discovered a subgroup with a higher 1-year mortality at the initiation of hemodialysis. Applying machine learning-derived classification to patients with ESRD may contribute to better risk stratification.
引用
- Komaru Y, Yoshida T, Hamasaki Y, et al. Hierarchical Clustering Analysis for Predicting 1-Year Mortality After Starting Hemodialysis. Kidney Int Rep. 2020. PMID: 32775818. doi:10.1016/j.ekir.2020.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。